CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Amneal Pharmaceuticals Inc Company Snapshot
Amneal Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amneal Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Swedish Orphan Biovitrum AB (publ) (2019 sales of $1.50 billion of which 100% was Pharmaceuticals), Biomarin Pharmaceutical Inc ($1.70 billion of which 100% was Global biotechnology), and United Therapeutics Corporation ($1.45 billion of which 41% was Remodulin).

Sales Analysis. Amneal Pharmaceuticals Inc reported sales of $1.63 billion for the year ending December of 2019. This represents a decrease of 2.2% versus 2018, when the company's sales were $1.66 billion. Contributing to the drop in overall sales was the 9.0% decline in Generics, from $1.44 billion to $1.31 billion. . However, these declines were partially offset by the increase in sales of Specialty (up 41.8% to $317.53 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Amneal Pharmaceuticals Inc
  Stock Performance Chart for Amneal Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 4.33
(Figures in U.S. Dollars)
1 Week 0.9%   13 Weeks -4.2%  
4 Weeks 29.6%   52 Weeks 33.2%  
 
Amneal Pharmaceuticals Inc Key Data:
  Ticker: AMRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,626,373,000
(Year Ending Jan 2020).
Employees: 5,500
  Currency: U.S. Dollars Market Cap: 1,296,537,906
  Fiscal Yr Ends: December Shares Outstanding: 299,431,387
  Share Type: Common Closely Held Shares: 183,677,757
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.